4D Molecular Therapeutics Stock (NASDAQ: FDMT) stock price, news, charts, stock research, profile.
Open | $11.46 |
Close | - |
Volume / Avg. | 735.65K / 939.06K |
Day Range | $11.20 - $11.74 |
52 Wk Range | 9.44 - 36.25 |
Market Cap | $602.33M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 19.68% |
Days to Cover | 21.96 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of 4D Molecular Therapeutics (NASDAQ:FDMT) through any online brokerage.
Other companies in 4D Molecular Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), Replimune Group (NASDAQ:REPL), Altimmune (NASDAQ:ALT), Opthea (NASDAQ:OPT) and Ironwood Pharmaceuticals (NASDAQ:IRWD).
4D Molecular Therapeutics has a consensus price target of $39.55.
The stock price for 4D Molecular Therapeutics (NASDAQ: FDMT) is $11.49 last updated September 23, 2024 at 2:49 PM EDT.
There are no upcoming dividends for 4D Molecular Therapeutics.
4D Molecular Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for 4D Molecular Therapeutics.
4D Molecular Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.